This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
This quick guide shows Which Index Funds Are Tax Efficient 2024 and the key factors to compare for better after-tax outcomes.
24,458 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
As drone-saturated battlefields rise, the world’s most advanced tanks drive a new era of defense spending. This repor...
Circle Ventures leads Tazapay’s Series B extension to $36M, backing rapid expansion of licensing and market entry in ...
As 2026 unfolds, REITs offer liquidity and steady income in a rate-sensitive environment. This report highlights the ...
Record exports could drive a U.S. fuel crunch as travelers hit the roads this summer, with diesel stocks near a 20-ye...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
Santa Clara County filed a landmark lawsuit against Meta, accusing the company of profiting from scam advertisements ...
Cantor8 announces a major expansion into Africa's mobile money scene, linking M-PESA and EVC Plus to its Canton Netwo...
Nextpower (NXT) 2026 earnings provide a window into the company’s growth engine and future trajectory. This piece bre...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
An in-depth look at Workhorse's path in 2026, focusing on earnings potential, drivers, and strategies for investors n...
NVIDIA’s Q1 report after the bell is a pivotal test for the AI hardware rally. Traders will parse data-center growth,...